Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study - Andre, T; Shiu, K; Kim, TW (Ann Oncol, 2025)